FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281293744> ?p ?o ?g. }

• W4281293744 endingPage "2060" @default.
• W4281293744 startingPage "2048" @default.
• W4281293744 abstract "The prodrug mycophenolate mofetil (MMF), which is presystemically hydrolyzed into the pharmacologically active compound mycophenolic acid (MPA), has been widely used for the prophylaxis of acute allograft rejection in solid organ transplantation. However, the huge variability in the plasma concentration level makes the development of MMF drug products difficult due to the great challenge of meeting the traditional bioequivalence (BE) limits. Numerous models have been developed in the past decade to explain the variability, with the emphasis on characterizing the enterohepatic circulation. While the variability arising from systemic appearance can also contribute to the remarkable MPA variability to a great extent, it has been ignored for long for this Biopharmaceutics Classification System class 2 drug. To improve the design of the BE study for this highly variable (HV) drug, the variability of MMF pharmacokinetic (PK) profiles focusing on the absorption process was explored in a population approach. A total of 81 Chinese adult liver transplant recipients were enrolled and had their plasma concentrations of MPA and its metabolites measured by HPLC during one visit or multiple visits in a long-term MMF regimen. The population models were developed using NONMEM, and the data and the results of the model were analyzed by R. Two population PK models of MMF focusing on the absorption process were developed based on the plasma concentrations of MPA and its major metabolite 7-O-MPA-β-glucuronide (MPAG). The MPA PK profiles were best characterized by a two-compartment disposition model with zero inter-individual variability (IIV) of elimination coefficient (K20), lag time, but considerable intra-individual variability (IAV) in the form of inter-occasion variability regarding systemic appearance coefficient, K20, and central volume of distribution, when just using MPA plasma concentrations as observations. The second model took into consideration the EHC by including MPAG profiles as well. The results from both models showcased that the IAV played a far more significant role than the IIV in accounting for the variability of the MMF systemic appearance. This is in line with what was found in the BE study: the within-subject variability (WSV) of BE measures largely exceeded the corresponding between-subject variability. The great WSV of MMF can be mechanistically explained by the interplay of dissolution and solubility with the gastrointestinal (GI) physiological dynamics, especially the gastric emptying (GE) in the fasting state regulated by migrating motor complex, and GE and pH variations in the fed state by the caloric content with irregular patterns of GI motility and secretion. The results implied that for the immediate-release solid oral dosage forms of MMF, running a regular in vitro dissolution test for the fasting state and developing a predictive in vitro dissolution test with sufficient simulation of the GE dynamics and proximal small intestinal pH fluctuations for the fed state would be excellent surrogates for the in vivo BE test. Furthermore, a physiologically based predictive in vitro dissolution test under both fasting and fed conditions would be a new trend for the BE studies of all other HV drug products." @default.
• W4281293744 created "2022-05-24" @default.
• W4281293744 creator A5000684412 @default.
• W4281293744 creator A5010099021 @default.
• W4281293744 creator A5052082793 @default.
• W4281293744 creator A5054791029 @default.
• W4281293744 creator A5058931227 @default.
• W4281293744 creator A5069778809 @default.
• W4281293744 creator A5077604881 @default.
• W4281293744 creator A5085453188 @default.
• W4281293744 date "2022-05-23" @default.
• W4281293744 modified "2023-10-16" @default.
• W4281293744 title "In Vitro Predictive Dissolution Test Should Be Developed and Recommended as a Bioequivalence Standard for the Immediate-Release Solid Oral Dosage Forms of the Highly Variable Mycophenolate Mofetil" @default.
• W4281293744 cites W1498305210 @default.
• W4281293744 cites W1499935265 @default.
• W4281293744 cites W1513692286 @default.
• W4281293744 cites W1549178882 @default.
• W4281293744 cites W1573587308 @default.
• W4281293744 cites W1826452022 @default.
• W4281293744 cites W1963856068 @default.
• W4281293744 cites W1965516994 @default.
• W4281293744 cites W1970297326 @default.
• W4281293744 cites W1970922323 @default.
• W4281293744 cites W1971387671 @default.
• W4281293744 cites W1994502792 @default.
• W4281293744 cites W2000951272 @default.
• W4281293744 cites W2009406967 @default.
• W4281293744 cites W2025695706 @default.
• W4281293744 cites W2034613829 @default.
• W4281293744 cites W2037698344 @default.
• W4281293744 cites W2039413451 @default.
• W4281293744 cites W2048189244 @default.
• W4281293744 cites W2049513349 @default.
• W4281293744 cites W2056213854 @default.
• W4281293744 cites W2064879413 @default.
• W4281293744 cites W2066128566 @default.
• W4281293744 cites W2069296221 @default.
• W4281293744 cites W2081336778 @default.
• W4281293744 cites W2088788142 @default.
• W4281293744 cites W2113953460 @default.
• W4281293744 cites W2126079216 @default.
• W4281293744 cites W2147213165 @default.
• W4281293744 cites W2152105855 @default.
• W4281293744 cites W2170870858 @default.
• W4281293744 cites W2313724273 @default.
• W4281293744 cites W2322666687 @default.
• W4281293744 cites W2330450581 @default.
• W4281293744 cites W2331078976 @default.
• W4281293744 cites W2341425180 @default.
• W4281293744 cites W2793376893 @default.
• W4281293744 cites W2900990332 @default.
• W4281293744 cites W2967647041 @default.
• W4281293744 cites W4235104046 @default.
• W4281293744 doi "https://doi.org/10.1021/acs.molpharmaceut.1c00792" @default.
• W4281293744 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35603895" @default.
• W4281293744 hasPublicationYear "2022" @default.
• W4281293744 type Work @default.
• W4281293744 citedByCount "4" @default.
• W4281293744 countsByYear W42812937442023 @default.
• W4281293744 crossrefType "journal-article" @default.
• W4281293744 hasAuthorship W4281293744A5000684412 @default.
• W4281293744 hasAuthorship W4281293744A5010099021 @default.
• W4281293744 hasAuthorship W4281293744A5052082793 @default.
• W4281293744 hasAuthorship W4281293744A5054791029 @default.
• W4281293744 hasAuthorship W4281293744A5058931227 @default.
• W4281293744 hasAuthorship W4281293744A5069778809 @default.
• W4281293744 hasAuthorship W4281293744A5077604881 @default.
• W4281293744 hasAuthorship W4281293744A5085453188 @default.
• W4281293744 hasConcept C108215921 @default.
• W4281293744 hasConcept C112705442 @default.
• W4281293744 hasConcept C116073593 @default.
• W4281293744 hasConcept C126322002 @default.
• W4281293744 hasConcept C149151106 @default.
• W4281293744 hasConcept C160492267 @default.
• W4281293744 hasConcept C185592680 @default.
• W4281293744 hasConcept C202751555 @default.
• W4281293744 hasConcept C2776239304 @default.
• W4281293744 hasConcept C2778033501 @default.
• W4281293744 hasConcept C2780035454 @default.
• W4281293744 hasConcept C2908647359 @default.
• W4281293744 hasConcept C2909935303 @default.
• W4281293744 hasConcept C2910701995 @default.
• W4281293744 hasConcept C2911091166 @default.
• W4281293744 hasConcept C42404028 @default.
• W4281293744 hasConcept C55493867 @default.
• W4281293744 hasConcept C71924100 @default.
• W4281293744 hasConcept C98274493 @default.
• W4281293744 hasConcept C99454951 @default.
• W4281293744 hasConceptScore W4281293744C108215921 @default.
• W4281293744 hasConceptScore W4281293744C112705442 @default.
• W4281293744 hasConceptScore W4281293744C116073593 @default.
• W4281293744 hasConceptScore W4281293744C126322002 @default.
• W4281293744 hasConceptScore W4281293744C149151106 @default.
• W4281293744 hasConceptScore W4281293744C160492267 @default.
• W4281293744 hasConceptScore W4281293744C185592680 @default.
• W4281293744 hasConceptScore W4281293744C202751555 @default.
• W4281293744 hasConceptScore W4281293744C2776239304 @default.
• W4281293744 hasConceptScore W4281293744C2778033501 @default.

• next